Enact Holdings Inc

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

On May 1, 2024, we announced the authorization of a new share repurchase program which allows for the repurchase of up to an additional $250 million of EHI’s common stock. Under the program, share repurchases may be made at the Company’s discretion from time to time in open market transactions in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, privately negotiated transactions, or by other means, including through Rule 10b5-1 trading plans. In conjunction with this authorization, we have entered into an agreement with Genworth Holdings, Inc. to repurchase its EHI shares on a pro rata basis as part of the program. We expect the timing and amount of any future share repurchases will be opportunistic and will depend on a variety of factors, including EHI’s share price, capital availability, business and market conditions, regulatory requirements, and debt covenant restrictions. The program does not obligate EHI to acquire any amount of common stock, it may be suspended or terminated at any time at the Company’s discretion without prior notice, and it does not have a specified expiration date.

The table below sets forth information regarding repurchases of our common shares during the three months ended June 30, 2024:

(1) In August 2023, we announced a share repurchase authorization which allows for the purchase of $100 million of EHI common stock, which was completed in June 2024. In May 2024, we announced a new share repurchase authorization which allows for the purchase of an additional $250 million of EHI common stock. The authorization has no expiration date.

Subsequent to quarter end, the Company purchased 406,945 shares at an average price of $31.01 through July 30, 2024.